Citation 105436

VAYA,J: BELINKY,PA: AVIRAM,M:. (1998). ANTIOXIDANT CONSTITUENTS FROM LICORICE ROOTS: ISOLATION, STRUCTURE ELUCIDATION AND ANTIOXIDATIVE CAPACITY TOWARD LDL OXIDATION.. 23(2)

Citation Details

Title	ANTIOXIDANT CONSTITUENTS FROM LICORICE ROOTS: ISOLATION, STRUCTURE ELUCIDATION AND ANTIOXIDATIVE CAPACITY TOWARD LDL OXIDATION.
Authors	VAYA,J: BELINKY,PA: AVIRAM,M:
Year	1998
Volume	23
Issue	2

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Glycyrrhiza glabra (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	HISPAGLABRIDIN A	None
2	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN,4'-O-METHYL:HISPAGLABRIDIN A	ACTIVE
3	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN,4'-O-METHYL:HISPAGLABRIDIN A	ACTIVE
4	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	GLABRIDIN,4'-O-METHYL:	None
5	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	GLABRIDIN	None
6	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN	ACTIVE
7	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN	ACTIVE
8	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	HISPAGLABRIDIN B	None
10	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPAGLABRIDIN B	ACTIVE
11	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPAGLABRIDIN B	ACTIVE
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CHALCONE,2'-4-4'-TRIHYDROXY-3-3'-DIISO-PRENYL:	None
13	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4-4'-TRIHYDROXY-3-3'-DIISO-PRENYL:LIQUIRITIGENIN,ISO:	WEAK ACTIVITY
14	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4-4'-TRIHYDROXY-3-3'-DIISO-PRENYL:LIQUIRITIGENIN,ISO:	ACTIVE
15	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	LIQUIRITIGENIN,ISO:	None
16	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	FORMONONETIN	None
17	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
18	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE

Show SPARQL Queries (1)